Jakub Lupták

1.1k total citations · 1 hit paper
10 papers, 512 citations indexed

About

Jakub Lupták is a scholar working on Molecular Biology, Immunology and Infectious Diseases. According to data from OpenAlex, Jakub Lupták has authored 10 papers receiving a total of 512 indexed citations (citations by other indexed papers that have themselves been cited), including 5 papers in Molecular Biology, 3 papers in Immunology and 2 papers in Infectious Diseases. Recurrent topics in Jakub Lupták's work include interferon and immune responses (2 papers), SARS-CoV-2 and COVID-19 Research (2 papers) and Protein Degradation and Inhibitors (2 papers). Jakub Lupták is often cited by papers focused on interferon and immune responses (2 papers), SARS-CoV-2 and COVID-19 Research (2 papers) and Protein Degradation and Inhibitors (2 papers). Jakub Lupták collaborates with scholars based in United Kingdom, Australia and United States. Jakub Lupták's co-authors include Leo C. James, Ian Goodfellow, Anna Albecka, Donna L. Mallery, Andrew P. Carter, Guido Papa, Jérôme Cattin‐Ortolá, Lawrence G. Welch, David Paul and Harvey T. McMahon and has published in prestigious journals such as Nature Communications, SHILAP Revista de lepidopterología and Current Biology.

In The Last Decade

Jakub Lupták

9 papers receiving 508 citations

Hit Papers

Furin cleavage of SARS-CoV-2 Spike promotes but is not es... 2021 2026 2022 2024 2021 50 100 150 200

Peers

Jakub Lupták
Joseph H. C. Nguyen United States
Chandana Tennakoon United Kingdom
Mei-Ling Li United States
Hazel Stewart United Kingdom
Samuel S. Shepard United States
Preti Jain United States
Jakub Lupták
Citations per year, relative to Jakub Lupták Jakub Lupták (= 1×) peers Eugene V. Sheval

Countries citing papers authored by Jakub Lupták

Since Specialization
Citations

This map shows the geographic impact of Jakub Lupták's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Jakub Lupták with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Jakub Lupták more than expected).

Fields of papers citing papers by Jakub Lupták

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Jakub Lupták. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Jakub Lupták. The network helps show where Jakub Lupták may publish in the future.

Co-authorship network of co-authors of Jakub Lupták

This figure shows the co-authorship network connecting the top 25 collaborators of Jakub Lupták. A scholar is included among the top collaborators of Jakub Lupták based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Jakub Lupták. Jakub Lupták is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

10 of 10 papers shown
1.
Lupták, Jakub, Dean Clift, Aamir S. Mukadam, et al.. (2025). State-selective small molecule degraders that preferentially remove aggregates and oligomers. Nature Communications. 16(1). 10486–10486.
2.
Kiss, L., Jakub Lupták, Claire F. Dickson, et al.. (2023). Trim-Away ubiquitinates and degrades lysine-less and N-terminally acetylated substrates. Nature Communications. 14(1). 2160–2160. 20 indexed citations
3.
Lupták, Jakub, Donna L. Mallery, Aminu S. Jahun, et al.. (2022). TRIM7 Restricts Coxsackievirus and Norovirus Infection by Detecting the C-Terminal Glutamine Generated by 3C Protease Processing. Viruses. 14(8). 1610–1610. 15 indexed citations
4.
Papa, Guido, Donna L. Mallery, Anna Albecka, et al.. (2021). Furin cleavage of SARS-CoV-2 Spike promotes but is not essential for infection and cell-cell fusion. PLoS Pathogens. 17(1). e1009246–e1009246. 215 indexed citations breakdown →
5.
Baxendale, Helen, David A. Wells, George Carnell, et al.. (2021). Critical Care Workers Have Lower Seroprevalence of SARS-CoV-2 IgG Compared with Non-patient Facing Staff in First Wave of COVID19. SHILAP Revista de lepidopterología. 7(3). 199–210. 3 indexed citations
6.
Zeng, Jingwei, Aamir S. Mukadam, Mariana Osswald, et al.. (2021). Target-induced clustering activates Trim-Away of pathogens and proteins. Nature Structural & Molecular Biology. 28(3). 278–289. 68 indexed citations
7.
Lupták, Jakub, Michał Biśta, David I. Fisher, et al.. (2019). Antibody fragments structurally enable a drug-discovery campaign on the cancer target Mcl-1. Acta Crystallographica Section D Structural Biology. 75(11). 1003–1014. 7 indexed citations
8.
Schiessl, Katharina, Tak Lee, Wouter Kohlen, et al.. (2019). NODULE INCEPTION Recruits the Lateral Root Developmental Program for Symbiotic Nodule Organogenesis in Medicago truncatula. Current Biology. 29(21). 3657–3668.e5. 178 indexed citations
9.
Jenkins, Gareth I., et al.. (2017). Learning about the molecular basis of plant responses to UV-B: a laboratory class at the University of Glasgow. 2017(1). 17–30. 1 indexed citations
10.
Lopušná, Katarína, et al.. (2016). Murine gammaherpesvirus targets type I IFN receptor but not type III IFN receptor early in infection. Cytokine. 83. 158–170. 5 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026